Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 11, No. 5, 2012, pp. 835-845
Bioline Code: pr12099
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 11, No. 5, 2012, pp. 835-845
© Copyright 2012 - Tropical Journal of Pharmaceutical Research
Intermittent Preventive Therapy and Treatment of Malaria during Pregnancy: A Study of Knowledge among Pregnant Women in Rufiji District, Southern Tanzania|
Mutagonda, Ritah; Kamuhabwa, Appolinary AR; Massawe, Siriel & Mpembeni, Rose
To assess the knowledge and awareness of pregnant women regarding the use of sulfadoxinepyrimethamine
(SP) for intermittent preventive therapy (IPT) and artemether-lumefantrine (ALu) for treatment
of malaria during pregnancy.
The study was conducted in Rufiji district, southern Tanzania from March 2011 to September 2011.
Four hundred and seventy (470) pregnant women in their second and third trimesters were interviewed when
attending antenatal clinics at the selected hospitals, health centers and dispensaries. Focus group discussions
(FGDs) were also conducted with 46 pregnant women at the health facilities in the district.
More than half (54.3 %) of pregnant women did not know if SP it was used for IPT. Most women
(76.6 %) did not know the use of SP for IPT in relationship with gestation age. Overall, the results show that
most women had very low knowledge about the use of SP for IPT. Forty three (9.1 %) pregnant women
reported to have had malaria during their current pregnancies. The antimalarials reported to be used by
pregnant women were quinine 18(42.9 %), SP (23.8 %), ALu (21.4%) and sulphamethoxyprazinepyrimethamine
(2.4%). Irrespective of the gestation age of pregnancy, almost all (98.3 %) pregnant women
perceived ALu as unsafe drug to be used during pregnancy.
Most pregnant women had minimum knowledge about the use and benefits of SP for IPT and
ALu for treatment of malaria during pregnancy. Some erroneous beliefs about the safety of ALu during
pregnancy were also identified among pregnant women. For effective implementation of IPT policy and
treatment of malaria during pregnancy, pregnant women should be sensitized and educated on the use and
benefits of antimalarial drugs.
Artemether-lumefantrine, Antenatal clinic, Knowledge, Pregnant women, Sulfadoxinepyrimethamine
Alternative site location: http://www.tjpr.org